Polyvascular Disease: Reappraisal of the Current Clinical Landscape
J Antonio Gutierrez1, Aaron W Aday2, Manesh R Patel1
1Duke Heart Center, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (J.A.G., M.R.P., W.S.J.).
Insights
Polyvascular disease, affecting multiple arteries, significantly increases cardiovascular risk. This review covers its risks and new treatments for this high-risk group.
Area of Science:
- Cardiology
- Vascular Biology
Background:
- Polyvascular disease involves atherosclerosis in two or more arterial beds, signifying elevated cardiovascular risk.
- Despite its known association with increased risk, the pathophysiology and optimal management of polyvascular disease remain incompletely understood.
Purpose of the Study:
- To review the contemporary understanding of cardiovascular risk in patients with polyvascular disease.
- To summarize emerging and novel therapeutic strategies for managing polyvascular disease.
Main Methods:
- Literature review of observational studies and clinical trials.
- Analysis of current antithrombotic and lipid-lowering therapies.
- Synthesis of data on risk stratification and treatment efficacy.
Main Results:
- Polyvascular disease is consistently linked to a higher incidence of ischemic events and mortality.
- Recent advancements in antithrombotic and lipid-lowering therapies offer new avenues for risk mitigation.
- Evidence suggests a need for tailored therapeutic approaches in this complex patient cohort.
Conclusions:
- Polyvascular disease represents a critical unmet need in cardiovascular medicine, demanding further research.
- Novel therapeutic strategies hold promise for improving outcomes in patients with polyvascular disease.
- A comprehensive understanding of pathophysiology and risk is essential for effective management.
Abstract:
Atherosclerosis within 2 or more arterial beds has been termed polyvascular disease. Although polyvascular disease has long been associated with heightened cardiovascular risk, much is still unknown regarding its pathophysiology and management. In this past decade, the field of cardiovascular disease has experienced exponential growth in terms of antithrombotic and lipid-lowering therapies aimed at mitigating ischemic events. This review describes the inherent risk associated with polyvascular disease in contemporary observational and clinical trial populations and summarizes novel therapies in this high-risk population.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Nephrotic Syndrome II : Assessment and Medical Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease IV: Nursing Management
